{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:35:09Z","timestamp":1790775309824,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Dr Lesley Ad\u00e8s"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.reprotox.2017.02.012","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T20:31:49Z","timestamp":1487795509000},"page":"146-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: Case report and literature review"],"prefix":"10.1016","volume":"69","author":[{"given":"Debra","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majella","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. (5)","key":"10.1016\/j.reprotox.2017.02.012_bib0005","first-page":"316","article-title":"Neuroleptic treatment at the onset of pregnancy and sacro-coccygeal teratoma of the fetus","volume":"20","author":"Bergamaschi","year":"1968","journal-title":"Bull. Fed. Soc. Gynecol. Obstet. Lang. Fr."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0010","unstructured":"FDA Drug Safety Communication, Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns, 2011. (Accessed 14 June 2016 2015)."},{"issue":"11","key":"10.1016\/j.reprotox.2017.02.012_bib0015","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.reprotox.2017.02.012_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.78.1.15","article-title":"Developmental changes in ionic channel activity in the embryonic murine heart","volume":"78","author":"Davies","year":"1996","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.reprotox.2017.02.012_bib0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<168::AID-TERA4>3.0.CO;2-0","article-title":"Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity","volume":"53","author":"Webster","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2017.02.012_bib0030","series-title":"Drug Toxicity in Embryonic Development II; Advances in Understanding Mechanisms of Birth Defects: Mechanistic Understanding of Human Developmental Toxicants","first-page":"161","article-title":"Cardiovascular active drugs","author":"Danielsson","year":"1997"},{"issue":"4","key":"10.1016\/j.reprotox.2017.02.012_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/tera.1420490408","article-title":"Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos, in vitro","volume":"49","author":"Spence","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2017.02.012_bib0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.reprotox.2012.06.008","article-title":"Antipsychotic drugs cause bradycardia in GD 13 rat embryos in vitro","volume":"34","author":"Gunnstr\u00f6m","year":"2012","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01415.x","article-title":"On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0050","series-title":"Product Monograph for Pimozide","author":"Orap","year":"2011"},{"issue":"7933","key":"10.1016\/j.reprotox.2017.02.012_bib0055","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(75)90567-X","article-title":"Association between maternal intake of diazepam and oral clefts","volume":"2","author":"Saxen","year":"1975","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.reprotox.2017.02.012_bib0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0890-6238(98)00035-5","article-title":"Is benzodiazepine use during pregnancy really teratogenic?","volume":"12","author":"Ornoy","year":"1998","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0065","first-page":"167","article-title":"Prospective assessment of pregnancy outcome following first trimester exposure to benzodiazepines","volume":"3","author":"Pastuszak","year":"1996","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0070","first-page":"295","article-title":"The uterine vascular bed: effect of adrenergic stimulation","volume":"21","author":"Greiss","year":"1963","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9378(72)90524-8","article-title":"Differential reactivity of myoendometrial and placental vasculature. Adrenergic responses","volume":"112","author":"Greiss","year":"1972","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0090-6980(82)90050-8","article-title":"Effect of the prostacyclin synthetase inhibitor tranylcypromine on uterine blood flow in pregnancy","volume":"23","author":"Clark","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.reprotox.2017.02.012_bib0085","first-page":"1149","article-title":"Effect of endothelium-derived nitric oxide and prostaglandins on the endothelium-dependent vascular refractoriness to angiotensin II in pregnant rabbits","volume":"44","author":"Nakamoto","year":"1992","journal-title":"Nihon Sanka Fujinka Gakkai zasshi"},{"issue":"6","key":"10.1016\/j.reprotox.2017.02.012_bib0090","first-page":"250","article-title":"Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels","volume":"52","author":"Keck,","year":"1991","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.reprotox.2017.02.012_bib0095","series-title":"Birth Defects and Drugs in Pregnancy","author":"Heinonen","year":"1977"},{"key":"10.1016\/j.reprotox.2017.02.012_bib0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF03011881","article-title":"Anaesthetic managemnt of labour and delivery in a woman taking longterm MAOI","volume":"42","author":"Pavy","year":"1995","journal-title":"Can. J. Anaesth."},{"issue":"3","key":"10.1016\/j.reprotox.2017.02.012_bib0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1520-6394(1997)6:3<124::AID-DA6>3.0.CO;2-D","article-title":"Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations","volume":"6","author":"Gracious","year":"1997","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.reprotox.2017.02.012_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00737-013-0386-3","article-title":"The comprehensive management of pregnant women with major mood disorders: a case study involving phenelzine, lithium, and quetiapine","volume":"17","author":"Frayne","year":"2014","journal-title":"Arch. Womens Mental Health"},{"issue":"3407","key":"10.1016\/j.reprotox.2017.02.012_bib0115","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.131.3407.1101","article-title":"E ffect of 5-hydroxytryptamine and iproniazid on pregnancy","volume":"131","author":"Poulson","year":"1960","journal-title":"Science"},{"key":"10.1016\/j.reprotox.2017.02.012_bib0120","doi-asserted-by":"crossref","DOI":"10.1677\/joe.0.0270147","article-title":"The effect of amine oxidase inhibitors on pregnancy","volume":"27","author":"Poulson","year":"1963","journal-title":"J. Endocrinol."},{"issue":"3419","key":"10.1016\/j.reprotox.2017.02.012_bib0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.132.3419.89.b","article-title":"Uterine vascular clamping: new procedure for the study of congenital malformations","volume":"132","author":"Brent","year":"1960","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.reprotox.2017.02.012_bib0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jmor.1051150210","article-title":"Effect of uterine vascular clamping on development of rat embryos three to fourteen days old","volume":"115","author":"Franklin","year":"1964","journal-title":"J. Morphol."},{"issue":"3","key":"10.1016\/j.reprotox.2017.02.012_bib0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/tera.1420070303","article-title":"Teratological experiments with ergotamine in mice, rats, and rabbits","volume":"7","author":"Grauwiler","year":"1973","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.reprotox.2017.02.012_bib0140","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/tera.1084","article-title":"Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism","volume":"64","author":"Skold","year":"2001","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.reprotox.2017.02.012_bib0145","doi-asserted-by":"crossref","DOI":"10.1002\/tera.1420410605","article-title":"Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat","volume":"41","author":"Webster","year":"1990","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.reprotox.2017.02.012_bib0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0892-0362(91)90045-X","article-title":"Fetal brain damage in the rat following prenatal exposure to cocaine","volume":"13","author":"Webster","year":"1991","journal-title":"Neurotoxicol. Teratol."},{"issue":"2","key":"10.1016\/j.reprotox.2017.02.012_bib0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/tera.1420350212","article-title":"Uterine trauma and limb defects","volume":"35","author":"Webster","year":"1987","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.reprotox.2017.02.012_bib0160","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.1971.tb08057.x","article-title":"Responses of the rat fetus to maternal injections of adrenaline and vasopressin","volume":"43","author":"Chernoff","year":"1971","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.reprotox.2017.02.012_bib0165","first-page":"764","article-title":"Transplacental passage of 3H ergotamine in the rat and determination of the intraamniotic embryotoxicity of ergotamine","volume":"29","author":"Leist","year":"1973","journal-title":"Experientia"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623816303951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623816303951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:45:36Z","timestamp":1760190336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623816303951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"alternative-id":["S0890623816303951"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2017.02.012","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal pregnancy outcome associated with high-dose maternal tranylcypromine therapy: Case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2017.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}